Both humoral and cellular immune responses are impaired in aged individuals, leading to decreased vaccine responses. Although T cell defects occur, defects in B cells play a significant role in age-related humoral immune changes. The ability to undergo class switch recombination (CSR), the enzyme for CSR, AID (activation-induced cytidine deaminase) and the transcription factor E47 are all decreased in aged stimulated B cells. We here present an overview of age-related changes in human B cell markers and functions, and also discuss some controversies in the field of B cell aging.
Introduction
Aging affects the humoral immune response both quantitatively and qualitatively, as specificity and class of antibody produced are changed (Frasca and Blomberg, 2009; Linton and Dorshkind, 2004) . The changes in the humoral immune response during aging significantly contribute to the increased susceptibility of the elderly to infectious diseases and reduce the protective effects of vaccination (McElhaney and Effros, 2009) . Not only decreased antibody production but also reduced duration of protective immunity following immunization has been reported (Steger et al., 1996) .
High-affinity protective antibodies are produced in the germinal centers (GC) of secondary lymphoid tissue during affinity maturation processes which are characterized by somatic hypermutation (SHM) of immunoglobulin (Ig) genes and subsequent selection of the genes encoding the best antibodies (Klein and Dalla-Favera, 2008; Longerich et al., 2006) .
The effects of age on antibody affinity maturation are controversial and results obtained by different groups are conflicting. Increased level of mutations in Ig genes have been reported in elderly individuals (Dunn-Walters et al., 1997; Kolar et al., 2006) , and attributed to accumulation rather than altered rate, as SHM occurs at the same rate in young and elderly individuals (Banerjee et al., 2002) . However, the same group has also shown that B cell repertoire as measured by spectratyping and DNA sequencing in individuals aged 86-94 has less Ig diversity than young especially in the more frail group (Gibson et al., 2009 mutated clones, as compared with those from elderly individuals; however, among the mutated clones, the frequency, location, and types of substitutions were similar between the young and the old groups (Radl et al., 1975) .
The decreased ability of aged individuals to produce highaffinity protective antibody responses against infectious agents results at least partially from defects in T cells, such as reduction in naïve T cells and a concomitant increase in memory/effector T cells (Pawelec et al., 2002) , loss in CD28 expression (Vallejo, 2005) , and is associated with an increase in cytomegalovirus (CMV) positivity (Grubeck-Loebenstein et al., 2009; Pawelec et al., 2009 ). Cytokine production and T cell proliferation are also affected with age (Pawelec et al., 2002) , as a consequence of signal transduction defects due to both lipid raft formation and intracellular effectors (Larbi et al., 2008; Sadighi Akha and Miller, 2005) .
Although B cell function may suffer from lack of optimal T cell help in aging, intrinsic changes in B cells also occur and have a significant impact on antibody production. By intrinsic changes we mean B cell functions not requiring external cellular (such as T cell) signals. These intrinsic changes, as already shown in murine B cells (Frasca et al., 2004) , include decreases in the E2A-encoded transcription factor E47, activation-induced cytidine deaminase (AID), and class switch recombination (CSR) measured by IgG production in culture supernatants and circle transcripts (CTs) in human B cells, in response to both polyclonal (Frasca et al., 2008) and influenza-specific (Frasca et al., 2010) stimulation. Objectives of our work are to establish biomarkers of human B cell function and associate these with a biologically relevant immune response, such as the influenza vaccine. Our results clearly indicate that AID can accurately track optimal immune responses and activity, and can be a valid predictor of vaccine effectiveness in humans.
